There's buzz around certain type 2 diabetes drugs, which not only help regulate blood sugar but can also lead to significant ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

KARACHI: Diabetes has led to a surge in severe health complications in Pakistan with nearly three million patients suffering ...

Mounjaro, which treats type 2 diabetes, has recently been approved for weight ... Any member of the public or health ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...